SEPTRA	phenytoin	1	1	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  		0	8183	202807	8183
SEPTRA	phenytoin	1	1	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  		0	8183	202807	8183
SEPTRA	phenytoin	1	2	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	1	2	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	1	3	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.  		0	8183	202807	8183
SEPTRA	phenytoin	1	3	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.  		0	8183	202807	8183
SEPTRA	phenytoin	2	1	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	2	1	true	positive	SEPTRA may inhibit the hepatic metabolism of phenytoin.  SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	2	2	true	positive	SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	2	2	true	positive	SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  		0	8183	202807	8183
SEPTRA	phenytoin	2	3	true	positive	SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.  		0	8183	202807	8183
SEPTRA	phenytoin	2	3	true	positive	SEPTRA, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%.  When administering these drugs concurrently, one should be alert for possible excessive phenytoin effect.  		0	8183	202807	8183
